2021 Q3 Form 10-K Financial Statement

#000164033422000145 Filed on January 21, 2022

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q3

Balance Sheet

Concept 2021 Q3 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.16K $99.16K $166.9K
YoY Change -40.6% -40.6% 136.93%
Cash & Equivalents $99.16K $99.16K $166.9K
Short-Term Investments
Other Short-Term Assets $50.42K $50.42K $9.560K
YoY Change 427.41% 427.41% 443.18%
Inventory
Prepaid Expenses $50.42K $9.559K
Receivables
Other Receivables
Total Short-Term Assets $149.6K $149.6K $176.5K
YoY Change -15.25% -15.25% 144.39%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $1.449K
YoY Change -100.0% -100.0% -52.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.920K $6.920K $6.920K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $6.921K $6.920K $8.370K
YoY Change -17.31% -17.32% -15.88%
TOTAL ASSETS
Total Short-Term Assets $149.6K $149.6K $176.5K
Total Long-Term Assets $6.921K $6.920K $8.370K
Total Assets $156.5K $156.5K $184.9K
YoY Change -15.35% -15.35% 124.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.006M $1.006M $836.3K
YoY Change 20.28% 20.28% 26.64%
Accrued Expenses $1.801M $1.801M $1.795M
YoY Change 0.35% 0.35% -3.59%
Deferred Revenue
YoY Change
Short-Term Debt $289.9K $289.9K $281.4K
YoY Change 3.04% 3.04% -51.55%
Long-Term Debt Due $417.7K $127.8K $409.2K
YoY Change 2.09% 0.0% 220.08%
Total Short-Term Liabilities $3.225M $3.225M $3.041M
YoY Change 6.07% 6.07% -5.89%
LONG-TERM LIABILITIES
Long-Term Debt $1.200K $1.200K $1.230K
YoY Change -2.44% -2.44% 16.04%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.200K $1.200K $1.230K
YoY Change -2.44% -2.44% 16.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.225M $3.225M $3.041M
Total Long-Term Liabilities $1.200K $1.200K $1.230K
Total Liabilities $3.226M $3.226M $3.042M
YoY Change 6.06% 6.06% -5.88%
SHAREHOLDERS EQUITY
Retained Earnings -$16.13M -$11.91M
YoY Change 35.46%
Common Stock $478.8K $462.7K
YoY Change 3.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.070M -$3.070M -$2.857M
YoY Change
Total Liabilities & Shareholders Equity $156.5K $156.5K $184.9K
YoY Change -15.35% -15.35% 124.98%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Public Float
EntityPublicFloat
74905415 USD
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
99158 USD
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
166941 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50419 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9559 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
149577 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
176500 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1449 USD
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
6921 USD
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
6921 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
6921 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
6921 USD
CY2021Q3 us-gaap Assets
Assets
156498 USD
CY2020Q3 us-gaap Assets
Assets
184870 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1005926 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
836290 USD
CY2021Q3 us-gaap Loans Payable Current
LoansPayableCurrent
127844 USD
CY2020Q3 us-gaap Loans Payable Current
LoansPayableCurrent
127844 USD
CY2021Q3 us-gaap Convertible Debt
ConvertibleDebt
289905 USD
CY2020Q3 us-gaap Convertible Debt
ConvertibleDebt
281351 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1801300 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1795071 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3224975 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3040556 USD
CY2021Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
1203 USD
CY2020Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
1234 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3226178 USD
CY2020Q3 us-gaap Liabilities
Liabilities
3041790 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
10000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
478825 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
10000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
478824365 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
462730684 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
462731 USD
CY2021Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 USD
CY2020Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
20000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12571207 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8597401 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16129612 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11906952 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3069680 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2856920 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156498 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
184870 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3155895 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
929142 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
61176 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
99563 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
3217071 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
1028705 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3217071 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1028705 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
60463 USD
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
103517 USD
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
753376 USD
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
3991040 USD
CY2021 mrge Interest Expense Penalty On Convertible Debt
InterestExpensePenaltyOnConvertibleDebt
191750 USD
CY2020 mrge Interest Expense Penalty On Convertible Debt
InterestExpensePenaltyOnConvertibleDebt
230942 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1005589 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4325499 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4222660 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5354204 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4222660 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5354204 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
471364258 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
424924258 shares
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-3149782 USD
CY2020 mrge Common Shares Issued For Conversion Of Debt And Interest Amount
CommonSharesIssuedForConversionOfDebtAndInterestAmount
4921471 USD
CY2020 mrge Sale Of Common Stock Amount
SaleOfCommonStockAmount
719000 USD
CY2020 mrge Common Stock Warrants Valued At Note Date
CommonStockWarrantsValuedAtNoteDate
6595 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5354204 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2856920 USD
CY2021 mrge Common Shares Issued For Conversion Of Debt And Interest Amount
CommonSharesIssuedForConversionOfDebtAndInterestAmount
1340263 USD
CY2021 mrge Sale Of Common Stock Amount
SaleOfCommonStockAmount
415000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
354637 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2021 mrge Ceo Gifted Shares Treated As Returned To The Company Five Million Amount
CEOGiftedSharesTreatedAsReturnedToTheCompanyFiveMillionAmount
0 USD
CY2021 mrge Gifted Shares Treated As Issued By The Company Amount
GiftedSharesTreatedAsIssuedByTheCompanyAmount
1900000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4222660 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3069680 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4222660 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5354204 USD
CY2021 us-gaap Depreciation
Depreciation
1449 USD
CY2020 us-gaap Depreciation
Depreciation
1581 USD
CY2021 us-gaap Legal Fees
LegalFees
17000 USD
CY2020 us-gaap Legal Fees
LegalFees
38098 USD
CY2021 mrge Loss On Change In Fair Value Of Convertible Debt
LossOnChangeInFairValueOfConvertibleDebt
753376 USD
CY2020 mrge Loss On Change In Fair Value Of Convertible Debt
LossOnChangeInFairValueOfConvertibleDebt
3991040 USD
CY2021 mrge Penalty On Convertible Debt
PenaltyOnConvertibleDebt
191750 USD
CY2020 mrge Penalty On Convertible Debt
PenaltyOnConvertibleDebt
230942 USD
CY2021 mrge Expenses Paid By Shareholder
ExpensesPaidByShareholder
28188 USD
CY2020 mrge Expenses Paid By Shareholder
ExpensesPaidByShareholder
29642 USD
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2254637 USD
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-40860 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7799 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
189296 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
247192 USD
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6229 USD
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-66865 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-821595 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-890373 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10100 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
28188 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
39742 USD
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
415000 USD
CY2020 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
719000 USD
CY2021 mrge Proceeds From Sale Of Convertible Debt Paid Directly To Vendor
ProceedsFromSaleOfConvertibleDebtPaidDirectlyToVendor
367000 USD
CY2020 mrge Proceeds From Sale Of Convertible Debt Paid Directly To Vendor
ProceedsFromSaleOfConvertibleDebtPaidDirectlyToVendor
297500 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
753812 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
986858 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-67783 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
96485 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166941 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70456 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99158 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166941 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
3232 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1533 USD
CY2021 mrge Stock Issued For Convertible Debt And Interest
StockIssuedForConvertibleDebtAndInterest
1340263 USD
CY2020 mrge Stock Issued For Convertible Debt And Interest
StockIssuedForConvertibleDebtAndInterest
4921471 USD
CY2021 mrge Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
4235 USD
CY2020 mrge Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
7807 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
20000 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
125000 USD
CY2020Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100500 USD
CY2021 us-gaap Debt Instrument Term
DebtInstrumentTerm
P180Y
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1486694 shares
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
125000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p>
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
99158 USD
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
166941 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2254637 USD
CY2021 mrge Related Parties
RelatedParties
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.</p>
CY2021Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
84906 USD
CY2020Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
162736 USD
CY2021Q3 mrge Remaining Unpaid Portion Due At T Regarding Cell Phone Installments
RemainingUnpaidPortionDueAtTRegardingCellPhoneInstallments
1203 USD
CY2020Q3 mrge Remaining Unpaid Portion Due At T Regarding Cell Phone Installments
RemainingUnpaidPortionDueAtTRegardingCellPhoneInstallments
1234 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
418952 USD
CY2020Q3 us-gaap Debt Current
DebtCurrent
410429 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
417749 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
409195 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1203 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1234 USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 mrge Preferred Stock Converted Into Common Stock
PreferredStockConvertedIntoCommonStock
200000000 shares
CY2020 mrge Debt Converted Into Common Stock
DebtConvertedIntoCommonStock
30579060 shares
CY2020 us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
790266 USD
CY2020 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4407546 USD
CY2020Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
513925 USD
CY2020 mrge Debt Conversion Converted Amount Accrued Interest
DebtConversionConvertedAmountAccruedInterest
4921471 USD
CY2020 mrge Common Stock Shares Offered And Sold
CommonStockSharesOfferedAndSold
17458334 shares
CY2020 mrge Common Stock Shares Offered And Sold Amount
CommonStockSharesOfferedAndSoldAmount
719000 USD
CY2020Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
20000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
527306 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
163683 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
527306 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
163683 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4428618 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1837458 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4428618 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1837458 USD
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4428618 USD
CY2021 mrge Net Operating Loss Carry Forwards Expire
NetOperatingLossCarryForwardsExpire
expiring from years 2034 to 2037
CY2020 mrge Accrued Unpaid Salary
AccruedUnpaidSalary
1728093 USD
CY2020Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1728093 USD
CY2020Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
66978 USD
CY2021 mrge Securities Hold By Landlord
SecuritiesHoldByLandlord
6921 USD

Files In Submission

Name View Source Status
0001640334-22-000145-index-headers.html Edgar Link pending
0001640334-22-000145-index.html Edgar Link pending
0001640334-22-000145.txt Edgar Link pending
0001640334-22-000145-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrge-20210731.xsd Edgar Link pending
mrge-20210731_cal.xml Edgar Link unprocessable
mrge-20210731_def.xml Edgar Link unprocessable
mrge-20210731_lab.xml Edgar Link unprocessable
mrge-20210731_pre.xml Edgar Link unprocessable
mrge_10k.htm Edgar Link pending
mrge_10k_htm.xml Edgar Link completed
mrge_ex21.htm Edgar Link pending
mrge_ex311.htm Edgar Link pending
mrge_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending